Cutaneous effects of transdermal levonorgestrel

Development and In Vitro Testing of a Novel Universal Transdermal Drug Delivery Platform to Reduce Medication Nonadherence

“…Studies on similarly designed TDDS delivering hormones have established low risk of skin irritation, pruritis, urticaria, and did not notice local effects of the medication [51][52][53]. Mild sub-acute irritation and erythema have been observed in patch formulations lacking drug as well, indicating that occlusion by the patch itself may contribute to skin irritation, while any local dermal effects by the drug were reversible [54]. As prednisolone can be used as a topical antiinflammatory (although hydrocortisone is preferred), local adverse dermal effects are rare, and reported in less than 4% of cases [55].…”

Development and In Vitro Testing of a Novel Universal Transdermal Drug Delivery Platform to Reduce Medication Nonadherence

“…Studies on similarly designed TDDS delivering hormones have established low risk of skin irritation, pruritis, urticaria, and did not notice local effects of the medication [51][52][53]. Mild sub-acute irritation and erythema have been observed in patch formulations lacking drug as well, indicating that occlusion by the patch itself may contribute to skin irritation, while any local dermal effects by the drug were reversible [54]. As prednisolone can be used as a topical antiinflammatory (although hydrocortisone is preferred), local adverse dermal effects are rare, and reported in less than 4% of cases [55].…”

Development and Testing of a Novel Universal Transdermal Drug Delivery Platform to Reduce Medication Nonadherence

“…Studies on similarly designed TDDS delivering hormones have established low risk of skin irritation, pruritis, urticaria, and did not notice local effects of the medication[50]- [52]. Mild sub-acute irritation and erythema have been observed in patch formulations lacking drug as well, indicating that occlusion by the patch itself may contribute to skin irritation, while any local dermal effects by the drug were reversible [53]. As prednisolone can be used as a topical anti-in ammatory (although hydrocortisone is preferred), local adverse dermal effects are rare, and reported in less than 4% of cases [54].…”

Development and In Vitro Testing of a Novel Universal Transdermal Drug Delivery Platform to Reduce Medication Nonadherence

“…Studies on similarly designed TDDS delivering hormones have established low risk of skin irritation, pruritis, urticaria, and did not notice local effects of the medication [51][52][53]. Mild sub-acute irritation and erythema have been observed in patch formulations lacking drug as well, indicating that occlusion by the patch itself may contribute to skin irritation, while any local dermal effects by the drug were reversible [54]. As prednisolone can be used as a topical antiinflammatory (although hydrocortisone is preferred), local adverse dermal effects are rare, and reported in less than 4% of cases [55].…”

Development and Testing of a Novel Universal Transdermal Drug Delivery Platform to Reduce Medication Nonadherence

“…Studies on similarly designed TDDS delivering hormones have established low risk of skin irritation, pruritis, urticaria, and did not notice local effects of the medication[50]- [52]. Mild sub-acute irritation and erythema have been observed in patch formulations lacking drug as well, indicating that occlusion by the patch itself may contribute to skin irritation, while any local dermal effects by the drug were reversible [53]. As prednisolone can be used as a topical anti-in ammatory (although hydrocortisone is preferred), local adverse dermal effects are rare, and reported in less than 4% of cases [54].…”

Development and In Vitro Testing of a Novel Universal Transdermal Drug Delivery Platform to Reduce Medication Nonadherence

“…Studies on similarly designed TDDS delivering hormones have established low risk of skin irritation, pruritis, urticaria, and did not notice local effects of the medication [51][52][53]. Mild sub-acute irritation and erythema have been observed in patch formulations lacking drug as well, indicating that occlusion by the patch itself may contribute to skin irritation, while any local dermal effects by the drug were reversible [54]. As prednisolone can be used as a topical antiinflammatory (although hydrocortisone is preferred), local adverse dermal effects are rare, and reported in less than 4% of cases [55].…”

Development and Testing of a Novel Universal Transdermal Drug Delivery Platform to Reduce Medication Nonadherence

“…Studies on similarly designed TDDS delivering hormones have established low risk of skin irritation, pruritis, urticaria, and did not notice local effects of the medication[50]- [52]. Mild sub-acute irritation and erythema have been observed in patch formulations lacking drug as well, indicating that occlusion by the patch itself may contribute to skin irritation, while any local dermal effects by the drug were reversible [53]. As prednisolone can be used as a topical anti-in ammatory (although hydrocortisone is preferred), local adverse dermal effects are rare, and reported in less than 4% of cases [54].…”